18 May 2022 , 03:40 PM
Net Loss of Panacea Biotec reported to Rs 25.31 crore in the quarter ended March 2022 as against net loss of Rs 18.31 crore during the previous quarter ended March 2021. Sales declined 48.03% to Rs 41.50 crore in the quarter ended March 2022 as against Rs 79.86 crore during the previous quarter ended March 2021. For the full year,net loss reported to Rs 93.58 crore in the year ended March 2022 as against net loss of Rs 14.44 crore during the previous year ended March 2021. Sales declined 31.45% to Rs 235.50 crore in the year ended March 2022 as against Rs 343.56 crore during the previous year ended March 2021.
| Particulars | Quarter Ended | Year Ended | ||||
| ? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
| Sales | 41.50 | 79.86 | -48 | 235.50 | 343.56 | -31 |
| OPM % | -46.70 | -20.17 | – | -30.86 | 0.14 | – |
| PBDT | -18.25 | -10.22 | -79 | -67.15 | 13.69 | PL |
| PBT | -25.31 | -16.79 | -51 | -93.58 | -12.88 | -627 |
| NP | -25.31 | -18.31 | -38 | -93.58 | -14.44 | -548 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
